Osteoporosis - Drug Pipeline Analysis and Market Forecasts to 2016

Questions: Discounts, Updates etc.

Pages: 43

Price (Single): $2000

Price (Departmental): $4000

Price (Company): $6000

Publication Date: 2010-03-15

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

Summary

Osteoporosis – Drug Pipeline Analysis and Market Forecasts to 2016 is an essential source of information and analysis on the global osteoporosis market. The report identifies the key trends shaping and driving the global osteoporosis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global osteoporosis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by industry experts.

Scope The scope of the report includes:

  • Annualized global osteoporosis market revenues data from 2001 to 2009, forecast forward for 7 years to 2016.
  • Geographic markets covered in this report include the US (United States), the UK (United Kingdom), Italy, Spain, Germany, France, and Japan.
  • Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
  • Analysis of the current and future market competition in the global osteoporosis market. Key players covered include Amgen, Merck & Pfizer.
  • Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for the future market associated with osteoporosis.


    • Reasons to buy

    The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

  • Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global osteoporosis market.
  • Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global osteoporosis market in future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
  • What’s the next big thing in the global osteoporosis market landscape? – Identify, understand and capitalize.

    • Table of Contents

  • 1 Table of contents 3
    • 1.1 List of Tables 5
    • 1.2 List of Figures 5
  • 2 Osteoporosis Market: Market Characterization 6

  • 3 Osteoporosis Therapeutics Market: Competitive Assessment 11

  • 4 Osteoporosis Therapeutics Market: Pipeline Assessment 21

  • 5 Osteoporosis Therapeutics Market: Implications for Future Market Competition 33

  • 6 Osteoporosis Therapeutics Market: Future Players in the Osteoporosis Therapeutics Market 34

  • 7 Osteoporosis Therapeutics Market: Appendix 38

  • 1.1 List of Tables
    • Table 1: Osteoporosis Therapeutics Market, Global, Revenues ($bn), 2001-2009 7
    • Table 2: Osteoporosis Therapeutics Market, Global, Revenue Forecasts ($bn), 2009-2016 8
    • Table 3: Drugs Approved by FDA to Prevent and/or Treat Osteoporosis 11
    • Table 4: Effect of Actonel 5mg on the Risk of Vertebral Fractures 15
    • Table 5: Mean Percent Increase in BMD from Baseline in Patients Taking Actonel 5mg 15
    • Table 6: Effect of Evista on Risk of Vertebral Fractures 16
    • Table 7: Evista - (60mg Once Daily) Related Increases in BMD for the Osteoporosis Treatment vs. Placebo 17
    • Table 8: Effect of Forteo on Risk of Vertebral Fractures in Postmenopausal Women with Osteoporosis 19
    • Table 9: Mean Percent Change in BMD in Postmenopausal Women with Osteoporosis 19
    • Table 10: Major Marketed Products Comparison in the Osteoporosis Therapeutics Market, 2010 20
    • Table 11: Osteoporosis Therapeutics – Most Promising Drugs Under Clinical Development, 2010 22
    • Table 12: Osteoporosis Therapeutics – Phase III Clinical Pipeline, 2010 26
    • Table 13: Osteoporosis Therapeutics – Phase II Clinical Pipeline, 2010 28
    • Table 14: Osteoporosis Therapeutics – Phase I Clinical Pipeline, 2010 30
    • Table 15: Osteoporosis Therapeutics – Pre-Clinical Pipeline, 2010 31
    • Table 16: Osteoporosis Therapeutics – Discovery Pipeline, 2010 31
    • Table 17: Amgen – Osteoporosis Pipeline Products, 2010 34
    • Table 18: Merck – Osteoporosis Pipeline Products, 2010 36
    • Table 19: Pfizer – Osteoporosis Pipeline Products, 2010 37
  • 1.2 List of Figures
    • Figure 1: Osteoporosis Therapeutics Market, Global, Revenues ($bn), 2001-2009 7
    • Figure 2: Osteoporosis Therapeutics Market, Global, Revenue Forecasts ($bn), 2009-2016 8
    • Figure 3: Opportunity and Unmet Need in the Osteoporosis Therapeutics Market, 2010 10
    • Figure 4: Strategic Competitor Assessment of the Major Marketed Products in Osteoporosis Therapeutics, 2010 12
    • Figure 5: Technology Trends Analytic Framework of the Osteoporosis Pipeline, 2010 21
    • Figure 6: Technology Trends Analytic Framework of the Osteoporosis Therapeutics Pipeline – Description, 2010 22
    • Figure 7: Osteoporosis Therapeutics Market, Global, Clinical Pipeline by Mechanism of Action (%), 2010 25
    • Figure 8: Osteoporosis Therapeutics Pipeline by Phase of Clinical Development, 2010 26
    • Figure 9: Implications for Future Market Competition in the Osteoporosis Therapeutics Market, 2010 33
    • Figure 10: Osteoporosis Therapeutics Market – Clinical Pipeline by Company (No. of Molecules), 2010 34
    • Figure 11: Methodology 39
    • Figure 12: Market Forecasting Model 42

    • Other users found this report page using the following search terms: Osteoporosis osteoporosis market drug pipeline drugs size 2010 prolia forteo osteoporosisdrugmarket

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.